Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$365M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$297M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$290M |
| 5 |
Applied Materials
AMAT
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$290M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Johnson Controls International
JCI
|
+$275M |
| 4 |
L3Harris
LHX
|
+$235M |
| 5 |
Visa
V
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.75% |
| 2 | Industrials | 11.17% |
| 3 | Healthcare | 8.52% |
| 4 | Consumer Discretionary | 7.23% |
| 5 | Financials | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Charles River Laboratories
CRL
$14.1B
| $13.6M | 0.03% |
69,584
+42,594
| +158% | +$8.74M |
|
702
Evolent Health
EVH
$528M
| $13.6M | 0.03% |
500,583
+133,380
| +36% | +$3.71M |
|
|
SLNO
703
DELISTED
Soleno Therapeutics
SLNO
| $13.5M | 0.03% |
+458,823
| New | +$2.78M |
|
704
United Parks & Resorts
PRKS
$2.01B
| $13.5M | 0.03% |
291,385
+200,305
| +220% | +$10.2M |
|
705
Essential Properties Realty Trust
EPRT
$6.68B
| $13.5M | 0.03% |
621,917
+612,088
| +6,227% | +$14.6M |
|
706
PUT
Immunovant
IMVT
$9.06B
| $13.4M | 0.03% |
+350,000
| New | +$7.91M |
|
707
PUT
Insmed
INSM
$27.1B
| $13.4M | 0.03% |
+532,000
| New | +$12.2M |
|
708
PUT
Oracle
ORCL
$414B
| $13.4M | 0.03% |
126,800
+26,800
| +27% | +$3.1M |
|
|
BRSP
709
BrightSpire Capital
BRSP
$619M
| $13.4M | 0.03% |
2,141,176
+266,798
| +14% | +$1.83M |
|
710
MoonLake Immunotherapeutics
MLTX
$1.32B
| $13.4M | 0.03% |
234,250
+164,909
| +238% | +$9.1M |
|
711
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $13.4M | 0.03% |
182,849
+176,260
| +2,675% | +$14.1M |
|
712
Knight Transportation
KNX
$11.2B
| $13.3M | 0.03% |
266,042
-890,575
| -77% | -$49.4M |
|
713
Box
BOX
$4.6B
| $13.3M | 0.03% |
550,321
+383,122
| +229% | +$10.9M |
|
|
WBS
714
DELISTED
Webster Financial
WBS
| $13.2M | 0.03% |
+326,942
| New | +$13.9M |
|
|
KREF
715
KKR Real Estate Finance Trust
KREF
$480M
| $13.2M | 0.03% |
1,109,546
-213,679
| -16% | -$2.63M |
|
|
GAP
716
The Gap Inc
GAP
$7.3B
| $13.2M | 0.03% |
+1,238,618
| New | +$12.6M |
|
717
Hayward Holdings
HAYW
$3.08B
| $13.2M | 0.03% |
+933,714
| New | +$12.8M |
|
718
CALL
Lam Research
LRCX
$389B
| $13.2M | 0.03% |
210,000
+110,000
| +110% | +$7.23M |
|
719
Landstar System
LSTR
$6.06B
| $13.2M | 0.03% |
+74,360
| New | +$14.3M |
|
720
CALL
Kenvue
KVUE
$37.2B
| $13.1M | 0.03% |
+653,900
| New | +$15.1M |
|
721
Goosehead Insurance
GSHD
$2.6B
| $13M | 0.03% |
175,016
-157,995
| -47% | -$10.6M |
|
|
ICPT
722
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $13M | 0.03% |
+702,900
| New | +$7.95M |
|
723
CALL
Dick's Sporting Goods
DKS
$16B
| $13M | 0.03% |
+120,000
| New | +$15.2M |
|
724
Bumble
BMBL
$368M
| $13M | 0.03% |
+873,208
| New | +$14.8M |
|
725
Regenxbio
RGNX
$550M
| $13M | 0.03% |
787,623
+238,677
| +43% | +$4.33M |
|
Similar funds
Dmitry Balyasny's Q3 2023 Portfolio in Review
As of Q3 2023, Dmitry Balyasny held 2,899 positions worth $49B, up 7.8% from $45.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny deployed $4.13B of net new capital in Q3 2023, opening 681 new positions and adding to 729 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was McDonald's, an estimated $290M trimmed.
- Dmitry Balyasny's largest Q3 2023 buy was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $365M increase.
- Dmitry Balyasny's biggest Q3 2023 reduction was McDonald's, cutting an estimated $290M.
- Dmitry Balyasny fully exited Life Storage, Inc. in Q3 2023, selling an estimated $165M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $49B portfolio in Q3 2023.
- Dmitry Balyasny opened 681 new positions and closed 701 in Q3 2023.
- Dmitry Balyasny's portfolio value rose 7.8% quarter-over-quarter to $49B.
Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.